Renvela Tablet (Sevelamer Carbonate) helps adults and children aged 6 years and older with chronic kidney disease (CKD) undergoing dialysis control elevated serum phosphorus levels. By binding dietary phosphate, it prevents complications such as bone disease and cardiovascular problems associated with hyperphosphatemia. For further guidance, visit FDA or Mayo Clinic.

Key Benefits & Uses

• Control Serum Phosphorus: Renvela lowers blood phosphate levels in CKD patients on dialysis (Drugs.com).

• Non-Calcium, Non-Metal: This composition reduces risks of hypercalcemia and vascular calcification (Healthline).

• Additional Health Benefits: It can improve lipid profiles and reduce all-cause mortality in CKD patients (PubMed).

How to Use

Take Renvela tablets orally with meals. Start with 0.8 to 1.6 grams, three times daily, and adjust the dose every two weeks according to serum phosphorus levels. Make sure to consult your healthcare provider before changing doses (WebMD).

Important Safety Information

• Avoid if you have bowel obstruction or hypersensitivity to sevelamer (MedlinePlus).

• Interactions: Renvela may affect absorption of certain medications; always consult your doctor first.

• Monitoring: Regularly check serum phosphorus and calcium levels to ensure safety.

Common Side Effects

• Gastrointestinal Issues: You may experience nausea, vomiting, diarrhea, constipation, abdominal pain, or gas (WHO).

• Serious Reactions: Rarely, bowel obstruction, ulceration, or perforation may occur. Seek immediate medical attention if severe symptoms appear.

Why Choose Renvela?

Renvela provides a calcium- and metal-free alternative for controlling high phosphorus levels. It works effectively without the risks associated with calcium-based binders. Furthermore, Renvela may improve lipid profiles and reduce mortality, making it a preferred choice for comprehensive CKD management (PubMed).